I'm not sure that if this decision says more about Rida, specifically, or maintenance therapies in general. fwiw, I wasn't particularly surprised by the FDA's decision. www.fda.gov/forconsumers/byaudience/forpatientadvocates/speedingaccesstoimportantnewtherapies/ucm128291.htm Comparison of Approval Times for Priority and Standard Review Drugs